Substance Abuse and Mental Health Services Administration
Strategic Prevention Framework for Prescription Drugs (SPF Rx)
Annual Reporting Tool
No Material or Nonsubstantive Change Justification
As the Substance Abuse and Mental Health Services Administration (SAMHSA) strives to be a data driven agency, it is requesting a no material or nonsubstantive change approval from the Office of Management and Budget (OMB) for OMB No 0930-0377 - Strategic Prevention Framework for Prescription Drugs (SPF Rx), Annual Reporting Tool, expiration date of December 31, 2025.
SAMHSA is requesting a no material or nonsubstantive change based on contractor feedback. These revisions were made to improve clarity of the data collection instrument which will reduce the burden to grantees who will be utilizing the instrument for reporting purposes. The following no material or nonsubstantive changes were made:
Correcting typos and formatting issues (e.g., the system will not have underline – so those were changed to bold).
Correcting the mis-numbering starting Q136/137.
Adding instructions where they were missing (e.g., adding a “Select all that apply” or “Specify”).
Minor changes in wording to reflect the underlying functionality of the system.
Q14 and 19 – adding an item to allow the system to skip the following sub-items if not relevant (e.g., for Q14 adding “We did not need or receive any guidance or T/TA that contributed to SPF Rx activities” and for Q19 adding “We did not have any key stakeholders, partners, or partner organizations participate in our SPF Rx related activities during the past Federal fiscal year”).
Making sure population served/reached section by demographics were appropriately consistently worded across the 6 sub-forms (by CSAP strategy type).
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| File Title | Notification of Intent to Use Schedule III, IV, or V Opioid Drugs |
| Author | Doug Slothouber |
| File Modified | 0000-00-00 |
| File Created | 2023-08-26 |